Loading clinical trials...
Loading clinical trials...
Transcesarean IUD Insertion: A Prospective Cohort Study
The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
This was a prospective clinical study with 90 patients undergoing cesarean section. After delivery of the placenta, a ParaGard® copper T380A IUD was inserted through the hysterotomy site. IUD placement was confirmed by visualization of the strings at the cervical os or via ultrasound at the 6 week postpartum visit. Subjects also received a phone call 6 months after IUD placement to ascertain physician follow-up and patient satisfaction. This telephone call was to ensure that each subject attended her postpartum visit, had an evaluation of IUD placement and then we performed a survey. This survey used a Likert Scale to measure each subject's satisfaction. The fields included very satisfied, satisfied, somewhat satisfied, neutral, somewhat unsatisfied, unsatisfied and very unsatisfied.
Age
18 - 50 years
Sex
FEMALE
Healthy Volunteers
Yes
Jacobi Medical Center
The Bronx, New York, United States
Montefiore Medical Center, Weiler Division
The Bronx, New York, United States
Start Date
August 1, 2008
Primary Completion Date
November 1, 2009
Completion Date
May 1, 2010
Last Updated
April 7, 2023
90
ACTUAL participants
Copper IUD placement at time Cesarean Delivery (Copper T 380A)
DEVICE
Lead Sponsor
Albert Einstein College of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions